About-cancer/treatment/drugs/defibrotide-sodium/zh

去纤蛋白钠

该页面包含有关去纤蛋白钠的简要信息，以及一些链接，这些链接指向有关该药物的使用，研究结果和正在进行的临床试验的更多信息。

美国品牌名称

Defitelio

FDA 批准

Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Defibrotide sodium is approved to treat:

• Hepatic veno-occlusive disease (also known as sinusoidal obstruction syndrome) in adults and children who also have kidney or lung problems after receiving a stem cell transplant.

More About Defibrotide Sodium

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Defibrotide Sodium - A lay language summary of important information about this drug that may include the following:

• warnings about this drug,

• what this drug is used for and how it is used,

• what you should tell your doctor before using this drug,

• what you should know about this drug before using it,

• other drugs that may interact with this drug, and

• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials Accepting Patients

Find Clinical Trials for Defibrotide Sodium - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.